A Randomised Phase II study comparing the efficacy of 5azacitidine alone versus combination therapy with lenalidomide and 5azacitidine in patients with higher risk myelodysplastic syndromes (MDS) and low marrow blast count acute myeloid leukaemia (AML). (MDS04)

Name: A Randomised Phase II study comparing the efficacy of 5azacitidine alone versus combination therapy with lenalidomide and 5azacitidine in patients with higher risk myelodysplastic syndromes (MDS) and low marrow blast count acute myeloid leukaemia (AML). (MDS04)
Creator: Health Data Australia Contributor Records
License: 暂无描述

Research Data Australia2024-08-03 收录

下载链接：

https://researchdata.edu.au/a-randomised-phase-aml-mds04/2538276

下载链接

链接失效反馈

官方服务：

资源简介：

Dataset includes: Data for 160 patients with newly diagnosed MDS. Patients were randomised to receive lenalidomide and 5azacitidine or 5azacitidine alone Demographic data, diagnostic data, treatment data, outcome data and measures of supportive care during treatment, Eg transfusion requirements, QoL

提供机构：

Health Data Australia Contributor Records